When clinicians document encounters for patients presenting with altered mental status due to psychoactive substance use, specificity is paramount for accurate billing and continuity of care. The ICD 10 code for substance induced psychosis serves as the primary diagnostic identifier for this condition, distinguishing it from schizophrenia or other primary psychotic disorders. This classification is essential for treatment teams to communicate the etiology of the patient's symptoms clearly, ensuring that the care plan addresses both the acute psychiatric presentation and the underlying substance use issue.
Understanding the Diagnostic Criteria
Substance induced psychosis is not a single diagnosis but a category of conditions triggered by the physiological effects of drugs or alcohol. The ICD-10 framework requires that the clinician establish a temporal relationship between the substance use and the onset of psychotic symptoms. These symptoms typically include hallucinations, delusions, or disorganized speech that are a direct pathophysiological consequence of the substance's toxic effects on the central nervous system. The distinction lies in the reversibility of the symptoms upon detoxification, which differentiates it from primary psychotic illnesses.
Core ICD-10 Code Specifications
The principal code for this diagnosis is F1x.5, where "x" represents the specific substance category. This seventh character extension is mandatory to indicate the current state of the condition. It is crucial to note that F1x.5 is reserved for cases where psychosis is the predominant manifestation; if the substance use disorder is the primary focus without psychotic features, a different code from the F10-F19 series would apply. The specificity of the substance—whether alcohol, opioids, cannabis, or cocaine—dictates the exact character following the F1x.5 format.
